For research use only — not for human consumption

Senna Research

GHK-Cu research: from a 1973 plasma finding to three repair pathways

GHK-Cu began with a 1973 observation about young plasma and aging liver cells. Fifty years on, it appears in three distinct repair pathways in the literature.

GHK-Cu research vial from Senna Research

GHK-Cu is a three-amino-acid peptide, glycine, histidine and lysine, with an unusually strong affinity for copper. It is one of the most extensively studied peptides in tissue-repair research and one of the most-cited copper peptides in dermal and wound-repair literature. Its history starts with a basic biology question, not a search for a marketable discovery.

A 1973 observation in liver tissue

In 1973, Loren Pickart was trying to understand why liver tissue from older donors behaved differently from tissue from younger donors. When he added blood plasma from young donors to liver cells taken from older donors, the older cells began producing proteins characteristic of younger tissue. Something in that plasma was doing the work.

It took years to isolate. The active compound turned out to be the GHK tripeptide bound to copper. That single observation launched five decades of continuous, published research spanning tissue repair, wound repair, collagen biology and gene expression, carried forward by Pickart until his death in December 2023, at age 85.

Reported plasma GHK levels and age

The number most associated with GHK is its reported decline in plasma: around 200 ng/mL at age 20 and closer to 80 ng/mL by age 60, a drop of roughly 60%, as described in the age-decline data from Pickart and Margolina (2018).

The middle of that curve is less clear. Exact per-decade figures for the 30s and 40s have not been independently published, so the decline is best read as two reported endpoints rather than a fully mapped trajectory.

Three repair pathways in the GHK-Cu literature

Fifty years of research place GHK-Cu in three distinct repair pathways.

Structural rebuild

Fibroblast studies report increased synthesis of collagen, elastin and glycosaminoglycans, the scaffolding of connective tissue.

Oxidative defense

Cell and animal models show upregulation of antioxidant enzymes.

Inflammation signaling

Tissue-repair models show modulation of pro-inflammatory cytokines.

Most compounds studied in repair research map to one of these pathways. GHK-Cu shows up in all three, which is part of why it is cited so often. Gene expression work extends the picture: a study using the Broad Institute Connectivity Map reports that GHK-Cu modulates roughly 4,000 genes. Pickart, Vasquez-Soltero and Margolina (2015) reviewed GHK as a natural modulator of multiple cellular pathways in skin regeneration.

How the field studies GHK-Cu, and the limits

Current research threads include copper-peptide complexes in dermatology and wound-care research, systemic GHK-Cu in tissue-regeneration literature, combination research with other repair-signaling peptides, and parallel work on collagen and copper metabolism.

The caveat matters. Most of this evidence comes from cell cultures, animal models and small topical studies. Touching three pathways in a dish is not the same as doing three things in a person.

Original posts on X

Compounds in this article

Mandatory research disclaimer

All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.

Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.

These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.